Dr. Martens plc
DOCS.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £4,500 | £69,200 | £128,900 | £181,200 |
| Dep. & Amort. | £72,500 | £72,300 | £54,200 | £36,900 |
| Deferred Tax | £0 | £0 | £22,800 | -£11,300 |
| Stock-Based Comp. | £7,200 | £4,000 | £500 | £5,200 |
| Change in WC | £84,300 | -£16,300 | -£145,900 | -£42,600 |
| Other Non-Cash | £27,800 | £38,700 | £16,800 | £15,000 |
| Operating Cash Flow | £196,300 | £167,900 | £77,300 | £184,400 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£8,400 | -£18,200 | -£51,400 | -£25,000 |
| Net Acquisitions | £0 | £0 | -£1,000 | £0 |
| Inv. Purchases | £0 | £0 | -£1,000 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £12,800 | £0 |
| Other Inv. Act. | -£6,900 | -£7,300 | -£10,000 | -£9,500 |
| Investing Cash Flow | -£15,300 | -£25,500 | -£50,600 | -£25,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£33,000 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | £0 | -£50,500 | £0 | £0 |
| Dividends Paid | -£9,500 | -£57,800 | -£58,400 | -£12,200 |
| Other Fin. Act. | -£91,700 | -£77,600 | -£41,100 | -£34,800 |
| Financing Cash Flow | -£134,200 | -£185,900 | -£99,500 | -£47,000 |
| Forex Effect | -£2,000 | -£2,900 | £2,300 | £2,000 |
| Net Chg. in Cash | £44,800 | -£46,400 | -£70,500 | £114,400 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £111,100 | £157,500 | £228,000 | £113,600 |
| End Cash | £155,900 | £111,100 | £157,500 | £228,000 |
| Free Cash Flow | £177,600 | £139,500 | £25,900 | £159,400 |